Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Quantitative Assessment of Antimicrobial Activity of PLGA Films Loaded with 4-Hexylresorcinol.

Kemme M, Heinzel-Wieland R.

J Funct Biomater. 2018 Jan 11;9(1). pii: E4. doi: 10.3390/jfb9010004.

2.

Characterization of a cypermethrin-degrading Methylobacterium sp. strain A-1 and molecular cloning of its carboxylesterase gene.

Diegelmann C, Weber J, Heinzel-Wieland R, Kemme M.

J Basic Microbiol. 2015 Nov;55(11):1245-54. doi: 10.1002/jobm.201500186. Epub 2015 Jul 1.

PMID:
26131623
3.

Studies on improving the embryonic stem cell test for an assessment of neuroembryotoxic effects.

Miechielsen N, Merz F, Heselich A, Kunz S, Heinzel-Wieland R, Pollet D.

J Stem Cells Regen Med. 2007 May 16;2(1):140-1. eCollection 2007. No abstract available.

PMID:
24692958
4.

Rat antigen-induced arthritis: cartilage alterations assessed with iodine-123-antileukoproteinase.

Kinne RW, Meyer P, Gründer W, Buchner E, Palombo-Kinne E, Heinzel-Wieland R, Becker W, Wolf F, Kalden JR, Burkhardt H.

J Nucl Med. 1998 Sep;39(9):1638-45.

5.

Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi.

Tomee JF, Hiemstra PS, Heinzel-Wieland R, Kauffman HF.

J Infect Dis. 1997 Sep;176(3):740-7.

PMID:
9291323
6.

The serine proteinase inhibitor antileukoproteinase specifically accumulates in normal but not in arthritic cartilage.

Burkhardt H, Meyer P, Buchner E, Palombo-Kinne E, Heinzel-Wieland R, Becker W, Wolf F, Kalden JR, Kinne RW.

J Rheumatol. 1997 Jun;24(6):1145-54.

PMID:
9195524
7.

Antibacterial activity of antileukoprotease.

Hiemstra PS, Maassen RJ, Stolk J, Heinzel-Wieland R, Steffens GJ, Dijkman JH.

Infect Immun. 1996 Nov;64(11):4520-4.

8.

Thrombin inhibitory and clot-specific fibrinolytic activities of the urokinase variant, M23 (rscu-PA-40 kDa/Hir).

Schneider J, Wnendt S, Saunders D, Heinzel-Wieland R, Wilffert B, Steffens G.

Eur J Pharmacol. 1996 Apr 29;302(1-3):69-77.

PMID:
8790994
9.

Potency of an oxidation-resistant mutant of secretory leukocyte proteinase inhibitor in lipopolysaccharide-induced emphysema in hamsters.

Stolk J, Heinzel-Wieland R, Saunders D, Dijkman JH, Steffens G.

Pulm Pharmacol. 1993 Mar;6(1):33-9.

PMID:
8097418
10.

Oxidation resistant muteins of antileukoproteinase as potential therapeutic agents.

Steffens GJ, Heinzel-Wieland R, Saunders D, Wolf B, Rudolphus A, Stolk J, Krarnps JA, Dijkman JA.

Agents Actions Suppl. 1993;42:111-21.

PMID:
8356918
11.

Oxidation-resistant variants of recombinant antileucoprotease are better inhibitors of human-neutrophil-elastase-induced emphysema in hamsters than natural recombinant antileucoprotease.

Rudolphus A, Heinzel-Wieland R, Vincent VA, Saunders D, Steffens GJ, Dijkman JH, Kramps JA.

Clin Sci (Lond). 1991 Dec;81(6):777-84.

PMID:
1662584
12.

Inhibitory characteristics and oxidant resistance of site specific variants of recombinant human antileukoproteinase (ALP).

Heinzel-Wieland R, Steffens GJ, Flohé L.

Biomed Biochim Acta. 1991;50(4-6):677-81.

PMID:
1801742

Supplemental Content

Loading ...
Support Center